Literature DB >> 28603979

Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin Overlap.

Mark McConnell1, Lauren Tal Grinspan2, Michael R Williams3, Melissa L Lynn4, Benjamin A Schwartz5, Ofer Z Fass4, Steven D Schwartz3, Jil C Tardiff1,4,6.   

Abstract

The progression of genetically inherited cardiomyopathies from an altered protein structure to clinical presentation of disease is not well understood. One of the main roadblocks to mechanistic insight remains a lack of high-resolution structural information about multiprotein complexes within the cardiac sarcomere. One example is the tropomyosin (Tm) overlap region of the thin filament that is crucial for the function of the cardiac sarcomere. To address this central question, we devised coupled experimental and computational modalities to characterize the baseline function and structure of the Tm overlap, as well as the effects of mutations causing divergent patterns of ventricular remodeling on both structure and function. Because the Tm overlap contributes to the cooperativity of myofilament activation, we hypothesized that mutations that enhance the interactions between overlap proteins result in more cooperativity, and conversely, those that weaken interaction between these elements lower cooperativity. Our results suggest that the Tm overlap region is affected differentially by dilated cardiomyopathy-associated Tm D230N and hypertrophic cardiomyopathy-associated human cardiac troponin T (cTnT) R92L. The Tm D230N mutation compacts the Tm overlap region, increasing the cooperativity of the Tm filament, contributing to a dilated cardiomyopathy phenotype. The cTnT R92L mutation causes weakened interactions closer to the N-terminal end of the overlap, resulting in decreased cooperativity. These studies demonstrate that mutations with differential phenotypes exert opposite effects on the Tm-Tn overlap, and that these effects can be directly correlated to a molecular level understanding of the structure and dynamics of the component proteins.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28603979      PMCID: PMC5575768          DOI: 10.1021/acs.biochem.7b00266

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  67 in total

1.  Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region.

Authors:  T Palm; S Graboski; S E Hitchcock-DeGregori; N J Greenfield
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  Tropomyosin and dilated cardiomyopathy: revenge of the actinomyosin "gatekeeper".

Authors:  Jil C Tardiff
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

3.  Localization of the two tropomyosin-binding sites of troponin T.

Authors:  J-P Jin; Stephen M Chong
Journal:  Arch Biochem Biophys       Date:  2010-06-08       Impact factor: 4.013

4.  Analysis of troponin-tropomyosin binding to actin. Troponin does not promote interactions between tropomyosin molecules.

Authors:  L E Hill; J P Mehegan; C A Butters; L S Tobacman
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

5.  Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.

Authors:  Briar R Ertz-Berger; Huamei He; Candice Dowell; Stephen M Factor; Todd E Haim; Sara Nunez; Steven D Schwartz; Joanne S Ingwall; Jil C Tardiff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

6.  Binding of troponin-T fragments to several types of tropomyosin. Sensitivity to Ca2+ in the presence of troponin-C.

Authors:  J R Pearlstone; L B Smillie
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

7.  Effect of calcium-sensitizing mutations on calcium binding and exchange with troponin C in increasingly complex biochemical systems.

Authors:  Svetlana B Tikunova; Bin Liu; Nicholas Swindle; Sean C Little; Aldrin V Gomes; Darl R Swartz; Jonathan P Davis
Journal:  Biochemistry       Date:  2010-03-09       Impact factor: 3.162

8.  Phosphorylation of tropomyosin extends cooperative binding of myosin beyond a single regulatory unit.

Authors:  Vijay S Rao; Ellisha N Marongelli; William H Guilford
Journal:  Cell Motil Cytoskeleton       Date:  2009-01

9.  Fluorescence resonance energy transfer between points on actin and the C-terminal region of tropomyosin in skeletal muscle thin filaments.

Authors:  Masao Miki; Hong Hai; Kimiko Saeki; Yuji Shitaka; Ken-Ichi Sano; Yuichiro Maéda; Takeyuki Wakabayashi
Journal:  J Biochem       Date:  2004-07       Impact factor: 3.387

10.  Förster resonance energy transfer structural kinetic studies of cardiac thin filament deactivation.

Authors:  Jun Xing; Jayant J Jayasundar; Yexin Ouyang; Wen-Ji Dong
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

View more
  18 in total

Review 1.  A new twist on tropomyosin binding to actin filaments: perspectives on thin filament function, assembly and biomechanics.

Authors:  William Lehman; Michael J Rynkiewicz; Jeffrey R Moore
Journal:  J Muscle Res Cell Motil       Date:  2019-02-15       Impact factor: 2.698

Review 2.  Biophysical Derangements in Genetic Cardiomyopathies.

Authors:  Melissa L Lynn; Sarah J Lehman; Jil C Tardiff
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

Review 3.  Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems.

Authors:  Andrea E Deranek; Matthew M Klass; Jil C Tardiff
Journal:  Pflugers Arch       Date:  2019-03-08       Impact factor: 3.657

4.  A Stochastic Multiscale Model of Cardiac Thin Filament Activation Using Brownian-Langevin Dynamics.

Authors:  Yasser Aboelkassem; Kimberly J McCabe; Gary A Huber; Michael Regnier; J Andrew McCammon; Andrew D McCulloch
Journal:  Biophys J       Date:  2019-08-09       Impact factor: 4.033

Review 5.  Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

6.  Structure and Dynamics of the Flexible Cardiac Troponin T Linker Domain in a Fully Reconstituted Thin Filament.

Authors:  Andrea E Deranek; Anthony P Baldo; Melissa L Lynn; Steven D Schwartz; Jil C Tardiff
Journal:  Biochemistry       Date:  2022-06-13       Impact factor: 3.321

7.  FRET-based analysis of the cardiac troponin T linker region reveals the structural basis of the hypertrophic cardiomyopathy-causing Δ160E mutation.

Authors:  Salwa Abdullah; Melissa L Lynn; Mark T McConnell; Matthew M Klass; Anthony P Baldo; Steven D Schwartz; Jil C Tardiff
Journal:  J Biol Chem       Date:  2019-08-06       Impact factor: 5.157

8.  Mechanism of Cardiac Tropomyosin Transitions on Filamentous Actin As Revealed by All-Atom Steered Molecular Dynamics Simulations.

Authors:  Michael R Williams; Jil C Tardiff; Steven D Schwartz
Journal:  J Phys Chem Lett       Date:  2018-06-05       Impact factor: 6.475

Review 9.  The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases.

Authors:  Stefania Fochi; Pamela Lorenzi; Marilisa Galasso; Chiara Stefani; Elisabetta Trabetti; Donato Zipeto; Maria Grazia Romanelli
Journal:  Genes (Basel)       Date:  2020-04-08       Impact factor: 4.096

Review 10.  Thin filament dysfunctions caused by mutations in tropomyosin Tpm3.12 and Tpm1.1.

Authors:  Joanna Moraczewska
Journal:  J Muscle Res Cell Motil       Date:  2019-07-03       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.